I
n the heart, excitation-contraction coupling is mediated by a mechanism known as Ca 2+ -induced Ca 2+ release. [1] [2] [3] In this process, membrane depolarization activates the voltage-dependent L-type Ca 2+ channel (LTCC), resulting in a small influx of external Ca 2+ into the cytosol. This Ca 2+ then binds to the cardiac Ca 2+ release channel/ryanodine receptor (RyR2) and opens the channel, leading to a large release of Ca 2+ from the sarcoplasmic reticulum (SR). In addition to Ca 2+ -induced Ca 2+ release, SR Ca 2+ release has long been known to occur spontaneously under conditions of SR Ca 2+ overload in the absence of membrane depolarizations. [4] [5] [6] [7] [8] [9] A number of conditions, including excessive β-adrenergic stimulation, Na + overload, elevated extracellular Ca 2+ concentrations, and fast pacing, can result in SR Ca 2+ overload, which, in turn, can trigger spontaneous SR Ca 2+ release in the form of propagating Ca 2+ waves. [4] [5] [6] [7] [8] [9] These spontaneous Ca 2+ waves (SCWs) can also alter membrane potential via activation of the electrogenic Na + /Ca 2+ exchanger (NCX), leading to delayed afterdepolarizations (DADs), triggered activities, and triggered arrhythmias. 8, [10] [11] [12] In fact, SCW-evoked DADs are a major cause of ventricular tachyarrhythmias (VTs) in heart failure.
12-14 SCW-evoked DADs also underlie the catecholaminergic polymorphic ventricular tachycardia (CPVT) associated with mutations in RyR2 and calsequestrin (CASQ2). 15 CPVT-causing RyR2 or CASQ2 mutations have been shown to enhance the propensity for SCWs and DADs. 15 Considering their critical role in arrhythmogenesis, suppressing SCWs represents a promising therapeutic strategy for the treatment of Ca 2+ -triggered arrhythmias. Because RyR2 mediates SCWs, inhibiting the RyR2 channel would be effective in suppressing SCWs. Indeed, reduction of RyR2 activity by tetracaine has been shown to inhibit spontaneous Ca 2+ release. 16 Furthermore, flecainide, a Na + -channel blocker, has recently been shown to suppress SCWs in cardiac cells and CPVT in both mice and humans by modifying the gating of the RyR2 channel. [17] [18] [19] Flecainide reduces the duration and increases the frequency of openings of the RyR2 channel. Similarly, we have recently shown that carvedilol, a nonselective β-blocker, also reduces the duration and increases the frequency of RyR2 openings, in addition to suppressing SCWs and CPVT, in mice. 20 Interestingly, by modifying the gating of RyR2, flecainide increases the frequency and reduces the mass of Ca 2+ sparks without affecting the SR Ca 2+ content. 18 These actions of flecainide effectively break up cell-wide propagating SCWs into nonpropagating spontaneous Ca 2+ release events (mini-waves or Ca 2+ sparks). 18, 19 These observations have led to the suggestion that breaking up SCWs by modifying RyR2 gating represents an effective approach to suppressing SCW-evoked DADs and triggered arrhythmia. 19 The sarco(endo)plasmic reticulum Ca 2+ ATPase (SERCA2a) in the heart also plays a critical role in determining the initiation and propagation of SCWs. [21] [22] [23] [24] [25] Increasing the activity of SERCA2a by removing phospholamban (PLN), an inhibitor of SERCA2a, has been shown to raise the SR Ca 2+ load and to markedly enhance the frequency and amplitude of Ca 2+ sparks. [26] [27] [28] Interestingly, despite severe SR Ca 2+ leak, no spontaneous cardiac arrhythmias in PLN-knockout (PLN-KO) mice have been reported. Furthermore, cell-wide propagating SCWs were hardly observed or were frequently aborted in PLN-KO cardiomyocytes. 29 These observations raise the important question regarding whether accelerating SR Ca 2+ uptake by removing PLN is proarrhythmic or antiarrhythmic. On the one hand, PLN-KO elevates SR Ca 2+ content and increases SR Ca 2+ leak, which would enhance the propensity for Ca 2+ -leak-induced DADs. On the other hand, PLN-KO aborts SCWs, which would suppress SCW-induced DADs and triggered activities. To address this seemingly paradoxical question, we used PLN-KO mice along with the CPVT RyR2-R4496C mutant mice that are prone to SCWs and DAD-evoked VTs. 20, 26 We examined the impact of PLN-KO on the spatial and temporal properties of SCWs and the occurrence of triggered activities in ventricular myocytes expressing the RyR2-R4496C mutant. We also determined the effect of PLN-KO on the susceptibility to stress-induced VTs in the CPVT RyR2-R4496C mutant mice. We found that the removal of PLN breaks SCWs and suppresses triggered activities in the RyR2-R4496C mutant ventricular myocytes, in addition to reducing stress-induced VTs in the RyR2-R4496C mutant mice. These data are consistent with the notion that breaking up propagating SCWs by accelerating SR Ca 2+ uptake is effective in suppressing Ca 2+ -triggered arrhythmias. Figure 1A , SCWs in RyR2-R4496C +/− ventricular myocytes originated from the middle (or either end) of the cell and propagated across the entire cell, similar to those reported previously. 20, [30] [31] [32] On the other hand, SCWs in the PLN −/− /RyR2-R4496C +/− ventricular myocytes frequently and simultaneously occurred at multiple sites and aborted shortly after their initiation without propagating across the entire cell. They appeared as short-lived mini-waves or clusters of Ca 2+ sparks ( Figure 1B ). Similar spontaneous Ca 2+ release events were also detected in ventricular myocytes from PLN −/− mouse hearts ( Figure 1C) , consistent with those shown previously. 29 Furthermore, this impact of PLN-KO was not limited to SCWs induced by elevated external Ca 2+ . We found that PLN-KO also breaks SCWs induced by isoproterenol (Online Figure I) ventricular myocytes, 93% of the total spontaneously released Ca 2+ was released in the form of Ca 2+ waves, whereas miniwaves and Ca 2+ sparks together consisted of only 7% of the total spontaneously released Ca 2+ ( Figure 3A and 3D ). In contrast, a majority of the spontaneously released Ca 2+ in PLN −/− / RyR2-R4496C +/− or PLN −/− cells was released as mini-waves (77% to 74%), whereas Ca 2+ waves and sparks consisted of 20% to 25% and 3% to 2% of the total released Ca, 2+ respectively ( Figure 3B-3D) . Furthermore, the occurrence of Ca We then recorded the membrane potential in these cells using the perforated patch current clamp technique. As shown in Figure 5 , RyR2-R4496C +/− ventricular myocytes displayed frequent DADs and spontaneously triggered APs (Figure 5A-a, 5C, and 5D) , which is consistent with the results reported previously. 31 /RyR2-R4496C +/− hearts using immunoblotting analysis. As shown in Figure 6A , there were no significant differences in their expression levels, except for RyR2 that exhibited a slightly higher (≈10%; P<0.05) expression in PLN −/− /RyR2-R4496C +/− hearts than in RyR2-R4496C +/− hearts. PLN-KO may also possibly break SCWs by altering the activities of LTCC, RyR2, or NCX, in addition to that of SERCA2a. For instance, mini-waves could result from reduced activity of LTCC or RyR2, which would reduce Ca Figure 6E ). Thus, enhanced SERCA2a activity, rather than reduced SR Ca 2+ content, decreased LTCC or RyR2 activity, or increased NCX activity, is a major contributor to the breakup of cell-wide SCWs.
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PLN-KO Protects the RyR2-R4496C +/− Mice From Stress-induced VTs
The RyR2-R4496C mutant mice are highly susceptible to CPVT, which is caused by DAD-induced triggered activities. 20, [30] [31] [32] The lack of triggered activities in PLN /calmodulin-dependent protein kinase II (CaMKII) in the heart has been shown to cause severe heart failure and dilated cardiomyopathy. 37, 38 It would be of interest to determine whether enhanced SR Ca 2+ leak as a result of PLN-KO could induce severe structural changes in the heart. To this end, we performed echocardiography on conscious RyR2-R4496C , and PLN −/− mice. We found that the RyR2-R4496C +/− mutation itself did not induce gross changes in cardiac structure and function (Online Table I ), which is in agreement with previous reports. 30, 31 We also found no severe structural defects in the PLN Table I ). Thus, as 
Discussion
A novel and surprising finding of the present study is that, despite severe SR Ca 2+ leak, PLN-KO mice are not susceptible to stress-induced VTs. In fact, on the contrary, PLN-KO protects a mouse model harboring the CPVT-causing RyR2-R4496C mutation from stress-induced VTs. Single-cell and intact heart Ca 2+ imaging show that PLN-KO effectively breaks the cellwide propagating SCWs into mini-waves and Ca 2+ sparks. Furthermore, PLN-KO markedly suppresses SCW-evoked triggered activities in RyR2-R4496C mutant ventricular myocytes. These observations indicate that spontaneous SR Ca 2+ leak, in the forms of mini-waves and Ca 2+ sparks (leaky SR) without generating cell-wide propagating SCWs, is not necessarily linked to triggered activities and triggered arrhythmias. Our data suggest that breaking up cell-wide propagating SCWs into mini-waves and Ca 2+ sparks is protective against Ca 2+ -triggered arrhythmias. An important question is how PLN-KO rescues the CPVT phenotype of the RyR2-R4496C mutant mice despite severe diastolic SR Ca 2+ leak. Increased SR Ca 2+ leak is often observed in cardiomyocytes derived from heart failure specimens and is thought to be a major cause of Ca 2+ -triggered arrhythmias. [12] [13] [14] This is because diastolic SR Ca 2+ leak can alter the membrane potential through the activation of the electrogenic NCX, resulting in DADs. These DADs can potentially trigger ectopic APs, which in turn can lead to triggered arrhythmia. 8, [10] [11] [12] However, whether a DAD is able to trigger an AP depends on its amplitude. An AP is triggered when the amplitude of a DAD reaches the activation threshold for Na + channels. Furthermore, the amplitude of a DAD is dependent on the amplitude and rate of rise of spontaneous SR Ca 2+ release. 10, 34 A total SR Ca 2+ release of 50% to 70% of the SR Ca 2+ load is required to generate DADs with amplitudes sufficient to produce an AP. 10 Therefore, the small diastolic SR Ca 2+ leak in the form of brief, localized Ca 2+ sparks or even mini-waves themselves are unlikely to produce DADs 41 and further show that enhanced SERCA2a activity suppresses triggered activities by breaking up cell-wide SCWs.
Although PLN-KO is effective in suppressing stress-induced VTs in the CPVT RyR2-R4496C mutant mice, whether PLN-KO would be beneficial in suppressing stress-induced VTs in other animal models or in humans with CPVT remains to be determined. Numerous studies have investigated the impact of PLN-KO on heart failure and cardiomyopathies, albeit not specifically on stress-induced arrhythmias. [42] [43] [44] For example, PLN-KO has been shown to rescue the heart failure and dilated cardiomyopathy phenotypes in a mouse model in which the cytoskeletal, muscle-specific LIM protein is ablated. 42 PLN-KO has also been shown to reverse the cardiac hypertrophy phenotype in a mouse model with calsequestrin overexpression. 43 However, PLN-KO does not rescue cardiac dysfunction in all mouse models of heart failure and cardiomyopathies tested. [45] [46] [47] For instance, despite the rescue of SR Ca 2+ handling, PLN-KO exaggerates heart failure and mortality in CaMKIIδc-overexpressing mice. 46 release in the CaMKIIδc-overexpressing or CASQ2-KO mice may be much severer than that in the RyR2-R4496C +/− mice. Consistent with this view, both CaMKIIδc-overexpressing and CASQ2-KO mice, but not RyR2-R4496C +/− mice, exhibit dilated cardiomyopathy, heart failure, or hypertrophy. 38, 49 Thus, it is possible that the enhanced SERCA2a activity as a result of PLN-KO may not be able to compensate fully for the much severer SR Ca 2+ leak caused by CaMKIIδc overexpression or CASQ2-KO, leading to chronic diastolic SR Ca 2+ leak, cardiomyopathies, and heart failure. Therefore, whether PLN-KO produces beneficial effects would be dependent on 
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the cause and severity of the defects of the disease model. Furthermore, in contrast to the observations in PLN-KO mice, PLN deficiency in humans as a result of nonsense mutations is associated with severe dilated cardiomyopathy and heart failure. 50 Hence, the beneficial effects of PLN-KO may also be species dependent.
In summary, we show that PLN-KO effectively breaks SCWs into mini-waves and Ca 2+ sparks in mouse ventricular myocytes expressing the SCW-prone, CPVT-causing RyR2-R4496C mutant. We further show that PLN-KO markedly suppresses SCW-evoked triggered activity and completely protects the RyR2-R4496C +/− mutant mice against CPVT. Thus, as with inhibition of RyR2 activity, breaking up SCWs by enhancing SERCA2a activity represents an effective means for suppressing Ca 2+ -triggered arrhythmias.
Limitations
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